Skip to main content

Clinical trial I3Y-MC-JPBO

A phase II study of Abemaciclib in patients with brain metastases secondary to hormone receptor positive breast cancer, non-small cell lung cancer, or melanoma

Organ Multiple
Trial status Trial closed
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Non
Sponsor Lilly
EudraCT Identifier 2014-004010-28
Inclusion criteria Brain metastasis
Last update